cbdMD's Total Assets for the quarter that ended in Mar. 2026 was $12.25 Mil.
During the past 12 months, cbdMD's average Total Assets Growth Rate was 4.80% per year.
During the past 3 years, the average Total Assets Growth Rate was -37.30% per year.
During the past 5 years, the average Total Assets Growth Rate was -44.50% per year.
During the past 10 years, the average Total Assets Growth Rate was 21.30% per year.
During the past 11 years, cbdMD's highest 3-Year average Total Assets Growth Rate was 282.70%. The lowest was -56.30%. And the median was 30.10%.
Total Assets is connected with ROA %. cbdMD's annualizedROA % for the quarter that ended in Mar. 2026 was -26.56%. Total Assets is also linked to Revenue through Asset Turnover. cbdMD's Asset Turnover for the quarter that ended in Mar. 2026 was 0.47.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
cbdMD's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
cbdMD Total Assets Related Terms
cbdMD Total Assets Historical Data
* Premium members only.
The historical data trend for cbdMD's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
cbdMD's Total Assets for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
cbdMD (YCBD) has a Total Assets of $12.25 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on cbdMD and its competitors.
Is cbdMD's Total Assets too high?
cbdMD's current Total Assets is $12.25 Mil. Overall, cbdMD has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's Total Assets compare to AKAN and GELS?
cbdMD's Total Assets of $12.25 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on cbdMD and its competitors. cbdMD's current Total Assets is $12.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.67 — trading 321.5% above its estimated fair value. The current Total Assets is $12.25 Mil. cbdMD's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For cbdMD (YCBD), the current Total Assets is $12.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is cbdMD (YCBD) Overvalued in 2026?
Based on GuruFocus' analysis, cbdMD stock appears to be overvalued.
The current stock price of $0.67 is trading 321.5% above its estimated GF Value™ of $0.16.
GuruFocus considers cbdMD to be Significantly Overvalued.
Key valuation signals for YCBD:
Total Assets: $12.25 Mil
GF Value™: $0.16 vs. price of $0.67 (321.5% above fair value)
No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score
Get the complete analysis for YCBD
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YCBD has been successfully added to your 
